EAGLE PHARMACEUTICALS, INC. Quarterly Other Assets, Current in USD from Q3 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
Eagle Pharmaceuticals, Inc. quarterly Other Assets, Current history and growth rate from Q3 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Other Assets, Current for the quarter ending June 30, 2023 was $3.82M, a 31.6% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $3.82M +$917K +31.6% Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $2.58M -$2.19M -45.9% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $3.26M +$1.86M +133% Dec 31, 2022 10-Q/A 2023-08-09
Q3 2022 $2.17M -$263K -10.8% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $2.9M -$1.56M -34.9% Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $4.76M -$395K -7.66% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $1.4M -$205K -12.8% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $2.43M -$1.24M -33.9% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $4.46M +$3.21M +257% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $5.16M +$4.47M +646% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $1.61M +$160K +11.1% Dec 31, 2020 10-K 2022-03-08
Q3 2020 $3.67M +$2.39M +187% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $1.25M +$984K +370% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $691K +$290K +72.3% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $1.45M +$1.31M +978% Dec 31, 2019 10-K 2021-03-05
Q3 2019 $1.28M -$393K -23.5% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $266K -$4.73M -94.7% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $401K -$179K -30.9% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $134K -$427K -76.1% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $1.67M +$821K +96.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 $5M +$4.31M +626% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 $580K -$635K -52.3% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $561K +$206K +58% Dec 31, 2017 10-K 2019-02-28
Q3 2017 $850K +$424K +99.5% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 $688K +$360K +110% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $1.22M +$1.01M +487% Mar 31, 2017 10-Q 2017-05-08
Q4 2016 $355K +$135K +61.4% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $426K +$267K +168% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $328K +$130K +65.7% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $207K +$33K +19% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $220K -$69K -23.9% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $159K -$170K -51.7% Sep 30, 2015 10-Q 2015-11-12
Q2 2015 $198K -$211K -51.6% Jun 30, 2015 10-Q 2015-08-11
Q1 2015 $174K -$38.1K -17.9% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 $289K Dec 31, 2014 10-K 2016-02-29
Q3 2014 $329K +$297K +928% Sep 30, 2014 10-K 2016-02-29
Q2 2014 $409K Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $212K Mar 31, 2014 10-Q 2014-05-15
Q3 2013 $32K Sep 30, 2013 10-K 2014-12-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.